Literature DB >> 17267285

Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?

Aleksandar Dakic1, Li Wu, Stephen L Nutt.   

Abstract

The transcription factor PU.1 is an essential regulator of haemopoiesis and a suppressor of myeloid leukaemia. PU.1 displays a complex expression pattern characterized by high expression in myeloid cells and low amounts in lymphoid cells. Based on this transcriptional profile, and the analysis of cell lines and mice expressing altered levels of PU.1, a model has been proposed where the concentration of PU.1 determines cell fate, whereas the graded reduction, but not absence, of PU.1 facilitates leukaemogenesis. The recent reports of mouse strains that enable the accurate determination of PU.1 expression and the conditional inactivation of PU.1 in adult haemopoiesis have led us to re-examine our understanding of the complex functions of PU.1. Here, we will discuss the data that, we believe, argue against the dosage-sensitive model of PU.1-mediated lineage commitment and leukaemogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267285     DOI: 10.1016/j.it.2007.01.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  29 in total

Review 1.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

2.  The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.

Authors:  Joanna Fares; Richard Koller; Rita Humeniuk; Linda Wolff; Juraj Bies
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

Review 3.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells.

Authors:  Anjali Bheda; Wei Yue; Anuradha Gullapalli; Julia Shackelford; Joseph S Pagano
Journal:  Leuk Lymphoma       Date:  2011-04-20

5.  Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Authors:  Christopher A Lord; David Savitsky; Raquel Sitcheran; Kathryn Calame; Jo Rae Wright; Jenny Pan-Yun Ting; Kristi L Williams
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development.

Authors:  Encarnacion Montecino-Rodriguez; Michael Fice; David Casero; Beata Berent-Maoz; Chad L Barber; Kenneth Dorshkind
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

7.  Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4.

Authors:  Esther Carreras; Sean Turner; Mark Barton Frank; Nicholas Knowlton; Jeanette Osban; Michael Centola; Chae Gyu Park; Amie Simmons; José Alberola-Ila; Susan Kovats
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

8.  The ETS Family Transcription Factors Etv5 and PU.1 Function in Parallel To Promote Th9 Cell Development.

Authors:  Byunghee Koh; Matthew M Hufford; Duy Pham; Matthew R Olson; Tong Wu; Rukhsana Jabeen; Xin Sun; Mark H Kaplan
Journal:  J Immunol       Date:  2016-08-05       Impact factor: 5.422

9.  IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.

Authors:  Sandra Bajaña; Sean Turner; Jinny Paul; Erola Ainsua-Enrich; Susan Kovats
Journal:  J Immunol       Date:  2016-01-08       Impact factor: 5.422

Review 10.  Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity.

Authors:  Susan Kovats
Journal:  Horm Behav       Date:  2012-04-25       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.